Kyron.bio WomenTech

Cell line engineering for imporved fertility treatment

Grant period2023-07-01 - 2024-01-31
Funding bodyEuropean Union
Call numberHORIZON-EIE-2022-SCALEUP-02
Grant number101114052
IdentifierG:(EU-Grant)101114052

Note: kyron.bio is a female led biotech company on a mission is to unclog bottlenecks in therapeutic protein production, allowing better drugs to reach patients. We are using synthetic biology to engineer mammalian cell lines for improved bioproduction, harnessing highly efficient enzymes from diverse life forms. Our preliminary data demonstrates a 3X yield gain for the amount of therapeutic produced in our system, with further gains in yield, activity and stability predicted post optimisation
   

Recent Publications

There are no publications


 Record created 2023-08-27, last modified 2023-08-27